Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  New Zealand Stock Exchange  >  Fisher & Paykel Healthcare Corporation Limited    FPH   NZFAPE0001S2

FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED

(FPH)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote New Zealand Stock Exchang…
11/30/2020 12/01/2020 12/02/2020 12/03/2020 12/04/2020 Date
35.92 35.51 34.95 33.64 32.3 Last
2764799 938816 649156 602850 1147397 Volume
+5.80% -1.14% -1.58% -3.75% -3.98% Change
Financials
Sales 2021 1 797 M 1 266 M 1 266 M
Net income 2021 442 M 311 M 311 M
Net cash position 2021 94,4 M 66,5 M 66,5 M
P/E ratio 2021 42,1x
Yield 2021 1,19%
Sales 2022 1 683 M 1 186 M 1 186 M
Net income 2022 400 M 282 M 282 M
Net cash position 2022 229 M 162 M 162 M
P/E ratio 2022 46,8x
Yield 2022 1,38%
Capitalization 18 604 M 13 107 M 13 107 M
EV / Sales 2021 10,3x
EV / Sales 2022 10,9x
Nbr of Employees 4 751
Free-Float 99,6%
More Financials
Company
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Company’s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by... 
More about the company
Notations Surperformance© of Fisher & Paykel Healthcare Corporation Limited
Trading Rating : Investor Rating :
More Ratings
All news about FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
12/03FISHER & PAYKEL HEALTHCARE CORPORATI : Ex-dividend day for interim dividend
FA
12/03FISHER & PAYKEL HEALTHCARE CORPORATI : Bonus dividend due to over-provision of t..
FA
11/24FISHER & PAYKEL HEALTHCARE : F&P Healthcare Raises Guidance as Pandemic Boosts S..
DJ
11/24FISHER & PAYKEL HEALTHCARE : F&P Healthcare Raises Guidance as Pandemic Boosts S..
DJ
11/24RECORD HALF YEAR RESULT FOR FISHER & : net profit up 86%
PU
11/22Australia shares at near 9-month high as biggest states reopen borders
RE
11/19FISHER & PAYKEL HEALTHCARE CORPORATI : half-yearly earnings release
11/13Australia shares end lower as traders shun risk on virus surge
RE
10/30Australia shares post biggest weekly drop in 6 months on mixed cues
RE
10/29Australian shares set for biggest weekly loss since April
RE
10/27Australian shares inch lower on virus, U.S. stimulus worries
RE
10/22Australia shares close lower as U.S. stimulus appears elusive
RE
10/15FISHER & PAYKEL HEALTHCARE : to announce half year results on 25 November 2020
PU
09/22Australia shares end lower as rising COVID-19 cases stoke lockdown worries
RE
09/21Australia shares hit over 2-month low as miners drag; U.S. stimulus woes weig..
RE
More news
News in other languages on FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
11/30MÄRKTE ASIEN/Börsen durch die Bank im Minus
11/30MÄRKTE ASIEN/Börsen drehen nach unten ab
11/19FISHER & PAYKEL HEALTHCARE CORPORATI : Veröffentlichung des Halbjahresergebnisse..
11/19FISHER & PAYKEL HEALTHCARE CORPORATI : publication des résultats semestriels
More news
Analyst Recommendations on FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
More recommendations
Stock Trading Strategies
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED - 12/01
The underlying trend is to the upside
BUY
More Stock Trading Analysis
Chart FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
Duration : Period :
Fisher & Paykel Healthcare Corporation Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 9
Average target price 30,34 NZD
Last Close Price 32,30 NZD
Spread / Highest target 18,2%
Spread / Average Target -6,08%
Spread / Lowest Target -33,9%
EPS Revisions
Managers
NameTitle
Lewis George Gradon Chief Executive Officer, Director & MD
Scott Andrew St. John Chairman
Lyndal York Chief Financial Officer
Andrew Robert Donald Somervell Vice President-Products & Technology
Nicholas Fourie VP-Information & Communication Technology
Sector and Competitors
1st jan.Capitalization (M$)
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED45.50%13 107
ABBOTT LABORATORIES24.22%184 876
MEDTRONIC PLC0.35%152 681
BECTON, DICKINSON AND COMPANY-10.74%70 408
HOYA CORPORATION23.88%46 370
ALIGN TECHNOLOGY, INC.86.97%41 138